The discovery of key diagnostic genes and significant changes in immune cells, specifically CD8+ cells and NK cells, in CAD combined with T2DM provides new insights into potential targets for diagnostic and therapeutic interventions. This evidence concerns the gene CD8A and coronary artery disorder.